Clinical Trials
4 trialsNCT02208375 2025-12-31
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02299999 2025-01-15
SAFIR02_Breast
UNICANCER
Phase 2 Active not recruiting
NCT02216786 2024-12-02
MANTA
Queen Mary University of London
Phase 2 Completed
NCT02583542 2020-02-25
TORCMEK
Queen Mary University of London
Phase 1/2 Unknown